Alzamend Neuro starts phase II trial of AL001 for bipolar disorder

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/1/2026

1. SPY
2. NVDA
3. AVAV
4. NKE
5. MU
6. DLR
7. EOSE
8. VSH
9. AAPL
10. TSLA

Go back to Alzamend Neuro starts phase II trial of AL001 for bipolar disorder
(NASDAQ: ALZN) Delayed: 1.20 +0.04 (3.45%)
Previous Close $1.16    52 Week High $ 
Open $1.13    52 Week Low $ 
Day High $1.25    P/E N/A 
Day Low $1.12    EPS $ 
Volume 2,269,759